Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.22.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
GS.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GS.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
HK.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.24NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XCFNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCFNSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
CH.1.1.32NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CH.1.1.32NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBB.1.5.109NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.109NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FR.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FR.1.5NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.10NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
HK.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.12NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
HK.33NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.33NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
GK.5.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.5.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBB.1.5.104NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.104NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
HH.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HH.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FL.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.1.6NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
GA.4.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.4.1.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
GW.5.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GW.5.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JE.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JE.1.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
EG.5.2.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.2.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.11NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
DV.7.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DV.7.1.5NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBB.1.16.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.23NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
GN.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GN.1.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JH.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JH.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
GA.2.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.2.1.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
GK.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.3.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBB.2.3.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used